Page last updated: 2024-10-25

diazoxide and Hyperpotassemia

diazoxide has been researched along with Hyperpotassemia in 1 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Research Excerpts

ExcerptRelevanceReference
"Diazoxide did not increase sarcolemmal adenosine triphosphate-sensitive potassium current in wild-type myocytes, although they demonstrated significant swelling during exposure to cardioplegia that was prevented by diazoxide."1.36Diazoxide maintenance of myocyte volume and contractility during stress: evidence for a non-sarcolemmal K(ATP) channel location. ( Al-Dadah, AS; Lawton, JS; Maffit, SK; Nichols, CG; Schuessler, RB; Sellitto, AD; Zhang, H, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sellitto, AD1
Maffit, SK1
Al-Dadah, AS1
Zhang, H1
Schuessler, RB1
Nichols, CG1
Lawton, JS1

Other Studies

1 other study available for diazoxide and Hyperpotassemia

ArticleYear
Diazoxide maintenance of myocyte volume and contractility during stress: evidence for a non-sarcolemmal K(ATP) channel location.
    The Journal of thoracic and cardiovascular surgery, 2010, Volume: 140, Issue:5

    Topics: Animals; ATP-Binding Cassette Transporters; Cardioplegic Solutions; Cardiotonic Agents; Cell Size; D

2010